The Therapeutic Approach for Malignant Melanoma: Case 2
The Therapeutic Approach for Malignant Melanoma
April 2017
- A 52-year-old female presented to her dermatologist with a pigmented lesion which had recently become darker; she had it removed for cosmetic reasons
- Pathology revealed a melanoma with a depth of 2.3 mm
- Genetic testing;BRAF V600mutation-positive
- LDH, WNL (174 UI/L)
- She underwent wide local excision and sentinel node mapping; staining is positive for melanoma in the right axillary node
- Complete dissection of the right axilla reveals no additional involved nodes
- CT of the chest, abdomen, and pelvis showed multiple masses in both lungs, the largest being 5 mm
- She underwent core-needle biopsy of the largest lung lesion
- Pathology revealed metastatic melanoma
- Mutation testing:BRAF-positive
- The patient is started on dabrafenib 150 mg bid and trametinib 2 mg qd
Recent Videos
Related Content
Atlas Examines Tolerability of Hedgehog Pathway Inhibitors and Transition to IO in mBCC
October 16th 2024Article
During a Case-Based Roundtable® event, Jennifer L. Atlas, MD, discussed treatment for a patient with basal cell carcinoma who reported challenging adverse events with hedgehog pathway inhibitor.
Read More
RELATIVITY-047 vs CheckMate 067 Matched Cohorts in Melanoma Show Similar Efficacy
October 10th 2024Article
During a Case-Based Roundtable® event, Ahmad Tarhini, MD, PhD, discussed the indirect comparison of ipilimumab plus nivolumab and nivolumab/relatlimab in advanced melanoma in the second article of a 2-part series.
Read More
